Sponsor or institution
Clinical trials and research at Immunocore Ltd
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Immunocore Ltd that are recruiting, at sites in 27 countries (most in Australia (4), Italy (4), Spain (4)). By phase: Phase 3 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 27Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IMC-P115C treatment for advanced PRAME-positive cancers | Phase 1 | Adelaide and 12 other locations | Recruiting | Sep 4, 2025 |
| Testing IMC-R117C for advanced cancers in specific patients | Phase 1/2 | Darlinghurst, Sydney and 12 other locations | Recruiting | Feb 21, 2025 |
| Comparing two treatments for advanced melanoma | Phase 3 | Tucson, Arizona and 210 other locations | Recruiting | Nov 1, 2023 |
| Comparing tebentafusp treatment to standard care for advanced melanoma | Phase 3 | Phoenix, Arizona and 81 other locations | Recruiting | Sep 22, 2022 |
All recruiting trials (4)
-
IMC-P115C treatment for advanced PRAME-positive cancers
This phase 1 study tests a new immune-engaging drug called IMC-P115C, alone or with standard treatments, in people with advanced PRAME-positive, HLA-A*02:01-positive cancers.
-
Testing IMC-R117C for advanced cancers in specific patients
This study is testing a new treatment called IMC-R117C to see if it can help people with advanced cancers like colorectal, esophageal, gastric, or ovarian cancer who have already tried other therapies.
-
Comparing two treatments for advanced melanoma
This study is testing if a new combination treatment for advanced melanoma can work better than the standard treatment for patients who have not received treatment before.
-
Comparing tebentafusp treatment to standard care for advanced melanoma
This study is testing a new treatment called tebentafusp for people with advanced melanoma to see if it works better than the usual care they’ve already received.
Quick answers
How many clinical trials run by Immunocore Ltd are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 27 countries. The most sites are in Australia (4 trials), Italy (4 trials), Spain (4 trials), Belgium (3 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.